GBI Research’s new report “South Korea Pharmaceutical Market Outlook 2013” provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceutical market. The report also provides competitive benchmarking for the country’s leading pharmaceutical companies and analyzes the M&A (Mergers and Acquisitions) and strategic partnerships that shape its pharmaceutical industry. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

1. South Korea Pharmaceutical Market Outlook 2013
South Korea Pharmaceutical Market Outlook 2013
Summary
GBI Research’s new report “South Korea Pharmaceutical Market Outlook 2013”
provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceutical
market. The report also provides competitive benchmarking for the country’s leading pharmaceutical
companies and analyzes the M&A (Mergers and Acquisitions) and strategic partnerships that shape its
pharmaceutical industry. It is built using data and information sourced from proprietary databases, primary
and secondary research and in-house analysis by GBI Research’s team of industry experts.
The South Korean pharmaceutical market is the 10th largest pharmaceutical market, globally. The industry is
highly fragmented, with almost all the domestic pharmaceutical companies having a strong portfolio of
generic products rather than expensive, branded drugs. For the entire pharmaceutical industry, an increase in
insurance coverage, an ageing population and favorable government initiatives are expected to drive future
growth in the pharmaceutical industry.
Improved Intellectual Property Rights (IPR), changing demographics, and government support have
contributed towards making the South Korean pharmaceutical industry attractive for multinational companies.
The South Korean government has signed Free Trade Agreements (FTA) with the US, Europe and India that
are aimed at improving the IPR framework in the country and making the pharmaceutical industry more
attractive for foreign investment. The immediate effects of the FTA may not be positive in all respects for the
generics-dominated domestic pharmaceutical industry. However, it is ultimately expected to bolster the South
Korean pharmaceutical industry by increasing transparency in government policies and enforcement, and price
competition in the private sector.
Scope
The macroeconomic environment of the pharmaceutical industry in South Korea, covering demographic
analysis, trends, drivers and barriers Important industry characteristics, including the regulatory authorities,
drug pricing, spending, insurance and reimbursement Market analysis of segments such as prescription
medicines, biotechnology and over-the-counter medicines Competitive profiling of major domestic and
international companies operating in the South Korea pharmaceutical market Analyses of the licensing,
partnership and M&A deals that took place between 2007 and 2012
Reasons to buy
Develop market-entry and market-expansion strategies by identifying the leading segments poised for strong
growth Devise a more specifically-tailored country strategy through understanding the key drivers and barriers
for the pharmaceutical market Develop key strategic initiatives by understanding leading companies’
key focus areas Accelerate and strengthen your market position by identifying key companies for M&As and
strategic partnerships
table Of Contents
South Korea Pharmaceutical Market Outlook 2013

2. 1 Table Of Contents
1 Table Of Contents 5
1.1 List Of Tables 7
1.2 List Of Figures 8
2 Introduction 9
3 South Korea Pharmaceutical Market Outlook 2013 – Overview 10
3.1 Global Pharmaceutical Industry Landscape 10
3.2 Macroscopic View Of The South Korea Pharmaceutical Market 10
3.3 Trade Balance 12
3.3.1 Exports 13
3.3.2 Imports 16
3.4 Demographic Analysis 18
3.4.1 Population Size, Growth, And Structure 18
3.4.2 Crude Death Rate 19
3.4.3 Causes Of Death 20
3.4.4 Crude Birth Rate 22
3.4.5 Infant Mortality Rate 23
3.4.6 Life Expectancy At Birth 24
3.4.7 Comparison Of Healthcare Indicators 25
3.5 Driver And Barriers Of South Korean Pharmaceutical Industry 26
3.5.1 Drivers 26
3.5.2 Barriers 28
4 South Korea Pharmaceutical Market Outlook 2013 – Industry Characteristics 29
4.1 Regulatory Agencies 29
4.1.1 Korea Food And Drug Administration 29
4.1.2 National Institute Of Food And Drug Safety Evaluation 30
4.2 Drug Pricing Policy 31
4.3 Healthcare Expenditure In South Korea 32
4.4 Healthcare Infrastructure 37
4.5 Insurance And Reimbursement 38
4.5.1 National Health Insurance 38
4.5.2 Long-term Care Insurance 39
4.5.3 Medical Aid 40
5 South Korea Pharmaceutical Market Outlook 2013 – Market Analysis 41
5.1 Over-the-counter Drugs 41
South Korea Pharmaceutical Market Outlook 2013

3. 5.2 Prescription Drugs 42
5.2.1 Patented Drugs 43
5.2.2 Generics 44
5.3 Biotechnology 45
6 South Korea Pharmaceutical Market Outlook 2013 – Key Trends 48
6.1 Rapid Consolidations In The Domestic Market 48
6.1.1 M&a Deals 48
6.1.2 Partnership Deals 50
6.1.3 Licensing Deals 51
6.2 Understanding Local Markets To Build R&d 52
6.3 Free Trade Agreements 53
6.3.1 Intellectual Property Rights Protection 54
6.3.2 Transparency In Healthcare Regulatory And Reimbursement Process 54
6.3.3 Unethical Business Practices 54
7 South Korea Pharmaceutical Market Outlook 2013 – Competitive Landscape 55
7.1 Key Foreign Companies 55
7.1.1 Glaxosmithkline 55
7.1.2 Sanofi 55
7.1.3 Pfizer 56
7.2 Key Domestic Companies 57
7.2.1 Dong-a 57
7.2.2 Green Cross 58
7.2.3 Hanmi 59
7.2.4 Jw Holdings Corporation (choongwae Holdings Co., Ltd.) 60
7.2.5 Yuhan Corporation 60
8 South Korea Pharmaceutical Market Outlook 2013 – The Way Forward 61
8.1 Outlook 61
8.2 Opportunities Ahead 61
8.2.1 Biosimilars 61
8.2.2 Stem Cell Research 61
9 South Korea Pharmaceutical Market Outlook 2013 – Appendix 63
9.1 Market Definitions 63
9.2 Abbreviations 63
9.3 Bibliography 64
9.4 Research Methodology 66
South Korea Pharmaceutical Market Outlook 2013

4. 9.4.1 Coverage 66
9.4.2 Secondary Research 66
9.4.3 Primary Research 66
9.4.4 Expert Panel Validation 67
9.5 Contact Us 67
9.6 Disclaimer 67
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
South Korea Pharmaceutical Market Outlook 2013